(Q44740266)

5 December 2017

Acute and continuation treatment adequacy with venlafaxine extended release compared with fluoxetine (English)

1 reference

5 December 2017

Kristina S Yu-Isenberg

1

1 reference

5 December 2017

Christina L Fontes

2

1 reference

5 December 2017

George J Wan

3

1 reference

5 December 2017

Erika C Geissler

4

1 reference

5 December 2017

Ann S M Harada

5

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

24

1 reference

5 December 2017

1

1 reference

5 December 2017

33-40

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

5 December 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.33.34807

Health care costs associated with depressive and anxiety disorders in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.33.34807

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.33.34807

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.33.34807

Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.33.34807

Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.33.34807

Outcomes of "inadequate" antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.33.34807

Managing depression in medical outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.33.34807

Patterns of antidepressant use in community practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.33.34807

Management of general medical patients with symptoms of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.24.1.33.34807

10.1592/PHCO.24.1.33.34807

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference